p38 MAPK: A Potential Target of Chronic Pain

E-ISSN： 1875-533x|21|38|4405-4418

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.38, 2014-01, pp. : 4405-4418

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Potential and Limitations of p38MAPK as a Drug Target for the Treatment of Hematological Malignancies

Current Drug Targets, Vol. 11, Iss. 7, 2010-07 ,pp. : 823-833

Bentham Science Publishers

Access to resources Recommend Favorite

The Potential of p38 MAPK Inhibitors to Modulate Periodontal Infections

Current Drug Metabolism, Vol. 10, Iss. 1, 2009-01 ,pp. : 55-67

Bentham Science Publishers

Access to resources Recommend Favorite

The ERK/MAPK pathway, as a target for the treatment of neuropathic pain

By Ma Weiya Quirion Remi

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 699-713

Informa Healthcare

Access to resources Recommend Favorite

Rational Design of Novel Potential p38 MAPK Inhibitors with Drug-like Properties Using Pharmacophore and Similarity-based Virtual Screening Procedures

Current Bioactive Compounds, Vol. 9, Iss. 1, 2013-03 ,pp. : 3-13

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms of the joint-protective effects of p38 MAPK inhibitors in rodent arthritis

By Mbalaviele Gabriel Monahan Joseph B

Expert Opinion on Drug Discovery, Vol. 3, Iss. 2, 2008-02 ,pp. : 163-172

Informa Healthcare

Access to resources Recommend Favorite